1. 5-Aza-2′-Deoxycytidine Enhances Maspin Expression and Inhibits Proliferation, Migration, and Invasion of the Bladder Cancer T24 Cell Line
   Huihui Zhang et al, 2013, Cancer Biotherapy and Radiopharmaceuticals CrossRef
2. Therapeutic approach of Cancer stem cells (CSCs) in gastric adenocarcinoma; DNA methyltransferases enzymes in cancer targeted therapy
   Syedeh Elham Norollahi et al, 2019, Biomedicine & Pharmacotherapy CrossRef
3. DNA methyltransferases and gastric cancer: insight into targeted therapy
   Sadegh Fattahi et al, 2018, Epigenomics CrossRef
4. Decreased expression of connective tissue growth factor in non-small cell lung cancer is associated with clinicopathological variables and can be restored by epigenetic modifiers
   Hanna Drzewiecka et al, 2016, Journal of Cancer Research and Clinical Oncology CrossRef
5. Trichostatin A sensitizes hepatoma cells to Taxol more than 5-Aza-dC and dexamethasone
   Thoria Donia et al, 2021, Drug Metabolism and Personalized Therapy CrossRef
6. The molecular mechanisms of apoptosis accompanied with the epigenetic regulation of the NY-ESO-1 antigen in non-small lung cancer cells treated with decitabine (5-aza-CdR)
   Varghese P. Inchakalody et al, 2023, European Journal of Pharmacology CrossRef
7. Trichostatin A sensitizes hepatoma cells to Taxol more than 5-Aza-dC and dexamethasone
   Thoria Donia et al, 2021, Drug Metabolism and Personalized Therapy CrossRef
8. DNMTs Are Involved in TGF-β1-Induced Epithelial–Mesenchymal Transitions in Airway Epithelial Cells
   Joo-Hoo Park et al, 2022, International Journal of Molecular Sciences CrossRef
9. 5-Aza-2′-deoxycytidine, a DNA methylation inhibitor, induces cytotoxicity, cell cycle dynamics and alters expression of DNA methyltransferase 1 and 3A in mouse hippocampus-derived neuronal HT22 cells
   Jing Yang et al, 2017, Journal of Toxicology and Environmental Health, Part A CrossRef
10. Epigenetic silencing of GDF1 disrupts SMAD signaling to reinforce gastric cancer development
    W Yang et al, 2016, Oncogene CrossRef